We believe clinical trials can work better so we're bringing the right people together to make trials faster, cheaper and more likely to succeed.
This is the most costly and lengthy part of the whole process and in recent years, several promising new treatments for Parkinson's have failed to show benefit in clinical trials.
We, and many others in the research community, believe the problem may not be that the drugs don't work, but that we're testing them in the wrong way.
So we are doing 2 things:
The Critical Path for Parkinson's is a multi-million pound project that will bring together researchers, drug companies and regulators.
We're working with the Critical Path Institute in the USA to change clinical trials so they're smarter, more likely to succeed and deliver new treatments for people with the condition.
If successful, the Critical Path for Parkinson's will mean more effective clinical trials, and ultimately help us achieve our mission to deliver new and better treatments in years, not decades.
New and better treatments for Parkinson's can only be developed if people take part in research.
We know that 70% of people with Parkinson's are keen to take part in research, but only 24% have.
So we bring people affected by the condition and research teams together.
And so far we've helped find participants for more than 100 research studies.
Browse our list of research studies if you're keen to take part in research.
Find out about the support we offer to researchers to help with recruiting participants.